Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||In vitro Maturation of Mammalian oocytes: outcomes and consequences|
|Citation:||Seminars in Reproductive Medicine, 2008; 26(2):162-174|
|Publisher:||Thieme Medical Publ Inc|
|Organisation:||Research Centre for Reproductive Health|
|Kelly M. Banwell and Jeremy G. Thompson|
|Abstract:||The application of in vitro maturation (IVM) of oocytes as a technology to assist animal production and clinical infertility treatment remains poor because of the reduced developmental competence of oocytes after IVM, despite several decades of research. Reduced meiotic maturation rates, fertilization rates, and blastocyst production reveal short-term developmental insufficiency of oocytes when compared with in vivo-matured counterparts. However, there is an increasing body of evidence that demonstrates the capacity of IVM efficiency to be improved, some of which is reviewed here. Of more concern is the role that IVM of oocytes may play in causing or accentuating long-term development and health of fetuses and neonates after in vitro production of embryos and embryo transfer. This is a largely unexplored area, yet the application of such techniques, especially the safety of clinical IVM, is significant and requires monitoring before acceptance as a routine procedure.|
|Keywords:||oocyte; maturation; IVM; mammals; mouse|
|Description:||Copyright © 2008 Thieme Medical Publishers|
|Appears in Collections:||Obstetrics and Gynaecology publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.